Bacterial eye infections, commonly known as bacterial conjunctivitis or pink eye, represent a prevalent ocular condition affecting people of all ages. Pathogenic bacteria such as Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae are frequent culprits behind these infections. The hallmark symptoms include redness, itching, and discharge from the eye, often accompanied by blurred vision and light sensitivity. Bacterial conjunctivitis is highly contagious and spreads through direct contact with contaminated hands, objects, or respiratory droplets. Proper hygiene, such as frequent handwashing and avoiding touching the face, is crucial for prevention. Antibiotic eye drops or ointments are commonly prescribed for bacterial eye infections to expedite recovery and minimize the risk of complications. Prompt medical attention is essential to prevent the spread of the infection and address any underlying issues. In severe cases, untreated bacterial eye infections can lead to corneal damage and vision impairment. Ongoing research focuses on developing more targeted and efficient antimicrobial treatments to combat antibiotic resistance and improve outcomes for individuals affected by bacterial eye infections.